AXSOME THERAPEUTICS INC (AXSM)
US05464T1043 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -296.38M | -239.24M | -187.13M | -130.40M | -102.90M | |||
| Depreciation Amortization | 7.00M | 6.83M | 4.40M | 80.00K | 20.00K | |||
| Change In Working Capital | -25.00M | -28.24M | 22.55M | -860.00K | 420.00K | |||
| Interest Paid | 18.41M | 16.73M | 7.69M | 4.63M | 2.10M | |||
| Taxes Paid | N/A | N/A | N/A | 180.00K | N/A | |||
| Other non cash items | 121.64M | 115.56M | 43.67M | 22.96M | 24.00M | |||
| OPERATING CASH FLOW | -192.73M | -145.08M | -116.51M | -108.23M | -78.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -610.00K | -582.00K | -700.00K | -310.00K | -50.00K | |||
| Other Investing Activity | N/A | 0.00 | -53.00M | N/A | N/A | |||
| INVESTING CASH FLOW | -610.00K | -582.00K | -53.70M | -310.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 29.84M | 85.00M | 45.00M | 0.00 | 28.34M | |||
| Stock Issued/Repurchased | 273.28M | 271.17M | 243.04M | 11.61M | 15.18M | |||
| Other Financing Activity | -24.86M | -25.16M | -3.46M | -490.00K | -1.10M | |||
| FINANCING CASH FLOW | 278.26M | 331.01M | 284.58M | 11.13M | 42.41M | |||
| CHANGE IN CASH | 84.92M | 185.35M | 114.37M | -97.41M | -36.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -192.73M | -145.08M | -116.51M | -108.23M | -78.46M | |||
| Capital Expenditure | -610.00K | -582.00K | -700.00K | -310.00K | -50.00K | |||
| FREE CASH FLOW | -193.34M | -145.66M | -117.21M | -108.54M | -78.51M | |||
All data in USD